Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michael Böhm
Angiotensin II Type 1 Receptor Antagonism Improves Hypercholesterolemia-Associated Endothelial Dysfunction
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
‹
1
2
Related publications
The Angiotensin II Type 1 Receptor and Receptor-Associated Proteins
Cell Research
Cell Biology
Molecular Biology
Angiotensin 1-7 Protects Against Angiotensin II-Induced Endoplasmic Reticulum Stress and Endothelial Dysfunction via Mas Receptor
PLoS ONE
Multidisciplinary
Leukocyte and Endothelial Angiotensin II Type 1 Receptors and Microvascular Thrombotic and Inflammatory Responses to Hypercholesterolemia
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
Angiotensin II Type 1 (AT1) Receptor Deficiency Halts the Progression of Age-Related Atherosclerosis in Hypercholesterolemia: Molecular Link Between the AT1 Receptor and Hypercholesterolemia
Hypertension Research
Internal Medicine
Cardiovascular Medicine
Physiology
Cardiology
Renin-Angiotensin System Blockade Improves Endothelial Dysfunction in Hypertension
Hypertension
Internal Medicine
Chronic Treatment With Angiotensin-(1-7) Improves Renal Endothelial Dysfunction in apolipoproteinE-deficient Mice
British Journal of Pharmacology
Pharmacology
Regulation of Angiotensin II Type 1 Receptor mRNA and Protein in Angiotensin II Induced Hypertension
Hypertension
Internal Medicine
Effects of Acute Angiotensin II Type 1 Receptor Antagonism and Angiotensin Converting Enzyme Inhibition on Plasma Fibrinolytic Parameters in Patients With Heart Failure
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Angiotensin Receptor Blocker Protection Against Podocyte-Induced Sclerosis Is Podocyte Angiotensin II Type 1 Receptor-Independent
Hypertension
Internal Medicine
